Stay updated on ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.

Latest updates to the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check11 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedRemoval of the 403 Forbidden error page content (HTML doctype, '403 Forbidden' message, and the Home link) from the page. This indicates the page no longer displays an error state and can render the normal study details view.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study content. Access to the study record is blocked.SummaryDifference19%

- Check60 days agoChange DetectedThe page shows an updated revision label (v3.6.6), replacing the previous v3.6.5. This appears to be a minor administrative update to the page's metadata rather than any changes to study data or eligibility.SummaryDifference0.0%

Stay in the know with updates to ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.